Aardvark Therapeutics Inc...

NASDAQ: AARD · Real-Time Price · USD
10.76
-0.50 (-4.44%)
At close: Aug 15, 2025, 3:59 PM
10.78
0.19%
After-hours: Aug 15, 2025, 04:10 PM EDT

Aardvark Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Cash & Equivalents
26M 26.5M 61.64M 82.28M 86.17M n/a 9.73M
Short-Term Investments
115.82M 124.76M 12.02M 83K 174K n/a 254K
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
2.19M 1.84M 2.63M 232K 108K n/a 13K
Receivables
n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
2.95M 3.29M 160K 136K 197K -9.99M 127K
Total Current Assets
144.77M 154.55M 74.14M 82.67M 86.99M n/a 10.37M
Property-Plant & Equipment
522K 628K 735K 841K 105K n/a 155K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
2.71M 2.47M 3.37M 1.07M 213K n/a 168K
Total Assets
147.47M 157.03M 77.51M 83.74M 87.2M n/a 10.54M
Account Payables
5.06M 2.56M 2.3M 666K 1.22M n/a 1.03M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
417K 390K 338K 323K n/a n/a 112K
Other Current Liabilities
4.84M 108K 558K 297K 933K n/a -67K
Total Current Liabilities
10.31M 5.98M 4.93M 2.61M 2.66M n/a 1.38M
Long-Term Debt
228K 336K 441K n/a n/a n/a 43.9M
Other Long-Term Liabilities
12K 24K 26K 126.76M 126.84M -9.1M 2K
Total Long-Term Liabilities
240K 360K 127.22M 127.3M 126.84M -9.1M 43.96M
Total Liabilities
10.55M 6.34M 132.15M 129.91M 129.51M -9.1M 45.34M
Total Debt
645K 726K 779K 868K 108K n/a 162K
Common Stock
n/a n/a n/a n/a n/a n/a n/a
Retained Earnings
-82M -67.64M -58.33M -49.55M -45.37M n/a -37.74M
Comprehensive Income
-3K 44K n/a n/a n/a -34.8M n/a
Shareholders Equity
136.93M 150.69M -54.64M -46.17M -42.31M 9.1M -34.8M
Total Investments
115.82M 124.76M 12.02M 83K 174K n/a 254K